Your Health. Your Family. Your Choice.
Administered by: Private Purchased by: Private
Life Threatening? No
Write-up: Information has been received from a registered pharmacist concerning her 12 year old daughter who on an unspecified date was vaccinated with the second dose of VARIVAX (Merck) (Lot # and expire date not reported), 0.5 ml, subcutaneously. Registered pharmacist stated that on an unspecified date, her daughter experienced shingles and added that her daughter''s shingles cleared up after she was administered acyclovir. The patient sought unspecified medical attention. Follow-up information was received from a physician concerning a female patient with no illness at the time of vaccination who on 03-JUL-2007 was vaccinated with the second dose of VARIVAX (Merck) (Lot # and expire date not reported), 0.5 ml, subcutaneously. Suspect therapy included the second dose of GARDASIL (Lot # and expire date not reported) administered on 27-JUL-2010. Concomitant therapy included the third dose of FLUVIRIN (Lot # and expire date not reported) administered on 22-AUG-2010. The physician stated that on 11-JAN-2011, the patient was diagnosed with shingles/Zoster. In 2011, the patient recovered. There were no laboratory diagnostics studies performed. The patient did not seek medical attention. Additional information is not expected.
Copyright © 2019 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166